Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ECULIZUMAB vs EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ECULIZUMAB vs EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL: Safety Overview

Metric ECULIZUMAB EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL
Total FAERS Reports 44,190 18,558
Deaths Reported 4,626 429
Death Rate 10.5% 2.3%
Hospitalizations 12,421 1,627
Average Patient Age 42.6 yrs 48.7 yrs
% Female Patients 59.5% 25.7%
Manufacturer Alexion Pharmaceuticals Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A